USPTO trademark

BIOLEGEND FROM REVVITY

Under examinationUSPTOFigurative markClass 1Class 5Class 9Class 42

"BIOLEGEND FROM REVVITY" is a figurative mark owned by Revvity, Inc., filed at the USPTO on December 23, 2025. It is under examination and covers classes 1, 5, 9 and 42.

View Revvity, Inc. portfolioGet this data via the API
Official USPTO record
BIOLEGEND FROM REVVITY trademark as filed
As filed with the USPTO
Status
Under examination
Since May 1, 2026
Filed
December 23, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99562551
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Figurative mark
4 classes
Ownership

Who owns BIOLEGEND FROM REVVITY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Revvity, Inc.

RVTY · Waltham, United States

6 trademarks in the portfolioView company

Representative

Kevin Oliver

Chief IP Counsel

Goods and services

What the mark covers

The products and services BIOLEGEND FROM REVVITY is filed for, grouped by Nice class.

  • Reagents for scientific and research use; Chemical preparations for scientific purposes; Reagents for scientific or medical research use; Assays and reagents for use in genetic research; Biochemical preparations for scientific use; Biochemical reagents, other than for medical or veterinary purposes; Biological preparation for use in cell cultures other than for medical or veterinary use; Chemical reagents, other than for medical or veterinary purposes; Buffer solutions for use in analytical chemistry; Biological preparations for use in the manufacture of pharmaceuticals; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes; Enzymes for scientific and research purposes; Assays for scientific and research use; Cell culture reagents for scientific and research use; In vitro diagnostic reagents for scientific purposes

  • Antibody reagents used for the detection of antigens in cells and tissue for medical purposes

  • Laboratory equipment and supplies, namely, test tubes; Laboratory equipment and supplies, namely, centrifuge tubes; Laboratory apparatus and instruments for extracting cells and cellular components for processing biological material, sample preparation, extracting cells, isolating cells, and tissue dissociation, not for medical purposes; Disposable plastic bioreactors for cell culturing

  • Providing online non-downloadable computer software platforms for scientific research; Providing online non-downloadable computer software platforms for use in molecular biology; Providing online non-downloadable computer software platforms for cell cycle analysis; Providing online non-downloadable computer software platforms for gene expression profiling; Providing online non-downloadable computer software platforms for cell sorting; Providing online non-downloadable computer software platforms for protein expression; Providing online non-downloadable computer software platforms for importing and analyzing data; Providing online non-downloadable computer software platforms for database management; Providing online non-downloadable computer software platforms for organizing and managing experiments; Providing online non-downloadable computer software platforms for analysis of scientific data and information for use in analyzing cells and particles using reflective and fluorescent properties produced by a flow cytometer apparatus or device; Compiling data for research purposes in the field of medical science and medical consultancy; Providing online non-downloadable computer software platforms for use in biotechnology research; Research and development services in the field of antibodies; Custom design and development of chemical reagents and biochemical assays; Research and development of conjugated antibodies

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notification of letter of suspension e-mailed
  2. Letter of suspension e-mailed
  3. Suspension letter written
  4. Assigned to examiner
  5. New application office supplied data entered
  6. Application filing receipt mailed
  7. New application entered
FAQ

About BIOLEGEND FROM REVVITY

Who owns the trademark "BIOLEGEND FROM REVVITY"?

The USPTO trademark "BIOLEGEND FROM REVVITY" (application 99562551) is owned by Revvity, Inc.

What is the status of "BIOLEGEND FROM REVVITY"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull BIOLEGEND FROM REVVITY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b7b-ac17-7551-9600-7674d0a1e240
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b7b-ac17-7551-9600-7674d0a1e240",
  "object": "trademark",
  "mark_text": "BIOLEGEND FROM REVVITY",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99562551",
  "filing_date": "2025-12-23",
  "nice_classes": [
    1,
    5,
    9,
    42
  ],
  "owners": [
    {
      "name": "Revvity, Inc.",
      "entity_id": "ent_019eb6fe-e3c7-760e-95e0-1a69f636d845"
    }
  ]
}